PADCEV EJFV
NDC 51144-030, ENFORTUMAB VEDOTIN, injection, powder, lyophilized, for solution, from SEAGEN INC..
- Product NDC
- 51144-030
- Status
- Listed
- Labeler
- SEAGEN INC.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761137
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51144-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENFORTUMAB VEDOTIN30 mg/3mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51144-030-01 | 51144003001 | 1 VIAL, SINGLE-DOSE in 1 BOX (51144-030-01) / 3 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b5631d3e-4604-4363-8f20-11dfc5a4a8edMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51144-030
Use it
Look up 51144-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51144-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51144-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.